These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9037918)

  • 21. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
    Nair SS; Zolotarskaya OY; Beckwith MJ; Ohman DE; Wynne KJ
    Macromol Biosci; 2017 Sep; 17(9):. PubMed ID: 28605136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico.
    González R; Welsh O; Ocampo J; Hinojosa-Robles RM; Vera-Cabrera L; Delaney ML; Gómez M
    Int J Dermatol; 2010 Sep; 49(9):1003-7. PubMed ID: 20931669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
    Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
    J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
    Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents.
    Nam C; Kim S; Sim Y; Chang I
    Skin Pharmacol Appl Skin Physiol; 2003; 16(2):84-90. PubMed ID: 12637783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance in acne.
    Eady EA
    Dermatology; 1998; 196(1):59-66. PubMed ID: 9557228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromycin-resistance of cutaneous bacterial flora in acne.
    Dreno B; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2001; 11(6):549-53. PubMed ID: 11701406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propionibacterium acnes resistance: a worldwide problem.
    Eady EA; Gloor M; Leyden JJ
    Dermatology; 2003; 206(1):54-6. PubMed ID: 12566805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Characterization of an Anti-Acne Gel Containing Siamese Crocodile (
    Phupiewkham W; Lu Q; Payoungkiattikun W; Temsiripong T; Jangpromma N; Lai R; Klaynongsruang S
    J Microbiol Biotechnol; 2018 May; 28(5):707-717. PubMed ID: 29807397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences].
    Lentze I; Ko HL; Höffler U
    Hautarzt; 1979 May; 30(5):242-7. PubMed ID: 156167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.